Skip to main content

Presence of Nucleosomes in Cerebrospinal Fluid of Glioblastoma Patients – Potential for Therapy Monitoring

  • Conference paper
  • First Online:
Book cover Circulating Nucleic Acids in Plasma and Serum

Abstract

Free nucleic acids are elevated in serum or plasma of patients with various cancers and indicate responsiveness to therapy. Circulating nucleosomes in serum and cerebrospinal fluid (CSF) of 45 patients were studied (10 with glioblastoma, 20 with non-acute neurological disorders, 10 with subarachnoid haemorrhage, and five with non-ruptured aneurysms). Patients with recurrent glioblastoma underwent tumour resection and local chemotherapy. Samples were taken before treatment and daily during the first week after surgery. There were no significant differences between pre-therapeutic nucleosome levels in the various patient groups. In patients with glioblastoma treated by surgery and local chemotherapy, levels of serum and CSF nucleosomes increased moderately during the week after surgery. Postoperatively, three of the 10 patients with glioblastoma developed cerebral oedema when CSF levels increased almost 200-fold reaching a maximum on day 3 after surgery in contrast to patients without oedema. Monitoring CSF levels of nucleosomes in patients with glioblastoma may indicate the development of postoperative complications and warrants further investigations.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Adamson C, Kanu OO, Mehta AI et al (2009) Glioblastoma multiforme: a review of where we have been and where we are going. Exp Opin Invest Drugs 18:1061–1083

    Article  CAS  Google Scholar 

  • Behin A, Hoang-Xuan K, Carpentier AF et al (2003) Primary brain tumours in adults. Lancet 361:323–331

    Article  PubMed  Google Scholar 

  • Geiger S, Holdenrieder S, Stieber P et al (2006) Nucleosomes in serum of patients with early cerebral stroke. Cerebro Vasc Dis 21:32–37

    Article  Google Scholar 

  • Geiger S, Holdenrieder S, Stieber P et al (2007) Nucleosomes as a new prognostic marker in early cerebral stroke. J Neurol 254:617–623

    Article  PubMed  Google Scholar 

  • Holdenrieder S, Stieber P (2009) Clinical use of circulating nucleosomes. Crit Rev Lab Med Sci 46:1–24

    Article  CAS  Google Scholar 

  • Holdenrieder S, Stieber P, Bodenmuller H et al (2001) Nucleosomes in serum as a marker for cell death. Clin Chem Lab Med 39:596–605

    Article  PubMed  CAS  Google Scholar 

  • Holdenrieder S, Stieber P, Pawel J et al (2004) Circulating nucleosomes predict the response to chemotherapy in patients with advanced non-small cell lung cancer. Clin Cancer Res 10:5981–5987

    Article  PubMed  CAS  Google Scholar 

  • Kremer A, Wilkowski R, Holdenrieder S et al (2005) Nucleosomes in pancreatic cancer patients during radiochemotherapy. Tumor Biol 26:44–49

    Article  CAS  Google Scholar 

  • Missler UMD, Wiesmann M, Friedrich C et al (1997) S-100 protein and neuron-specific enolase concentrations in blood as indicators of infarction volume and prognosis in acute ischemic stroke. Stroke 28:1956–1960

    Article  PubMed  CAS  Google Scholar 

  • Perry J, Chambers A, Spithoff K et al (2007) Gliadel wafers in the treatment of malignant glioma: a systematic review. Curr Oncol 14:189–194

    Article  PubMed  CAS  Google Scholar 

  • Rainer TH, Wong LKS, Lam W et al (2003) Prognostic use of circulating plasma nucleic acid concentrations in patients with acute stroke. Clin Chem 49:562–569

    Article  PubMed  CAS  Google Scholar 

  • von Eckardstein KL, Reszka R, Kiwit JC (2005) Intracavitary chemotherapy (paclitaxel/carboplatin liquid crystalline cubic phases) for recurrent glioblastoma - clinical observations. J Neurooncol 74:305–309

    Article  Google Scholar 

  • Wunderlich MT, Ebert AD, Kratz T etal (1999) Early neurobehavioral outcome after stroke is related to release of neurobiochemical markers of brain damage. Stroke 30:1190–1195

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Stefan Holdenrieder .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer Science+Business Media B.V.

About this paper

Cite this paper

Holdenrieder, S., Spuler, A., Tischinger, M., Nagel, D., Stieber, P. (2010). Presence of Nucleosomes in Cerebrospinal Fluid of Glioblastoma Patients – Potential for Therapy Monitoring. In: Gahan, P. (eds) Circulating Nucleic Acids in Plasma and Serum. Springer, Dordrecht. https://doi.org/10.1007/978-90-481-9382-0_11

Download citation

Publish with us

Policies and ethics